首页分子通Ristomycin A aglycone, 41-((((4-butylphenyl)methyl)amino0methyl)-22,31-dichloro-38-de(methoxycarbonyl)-7-demethyl-19-deoxy-N15-((1,1-dimethylethoxy)carbonyl)-38-((methylamino)carbonyl)-
Ristomycin A aglycone, 41-((((4-butylphenyl)methyl)amino0methyl)-22,31-dichloro-38-de(methoxycarbonyl)-7-demethyl-19-deoxy-N15-((1,1-dimethylethoxy)carbonyl)-38-((methylamino)carbonyl)- | 562105-33-3
Ristomycin A aglycone, 41-((((4-butylphenyl)methyl)amino0methyl)-22,31-dichloro-38-de(methoxycarbonyl)-7-demethyl-19-deoxy-N15-((1,1-dimethylethoxy)carbonyl)-38-((methylamino)carbonyl)-
Ristomycin A aglycone, 41-((((4-butylphenyl)methyl)amino)methyl)-22, 31-dichloro-38-de(methoxycarbonyl)-7-demethyl-19-deoxy-38-((methylamino)carbonyl)-
Antiretroviral Activity of Semisynthetic Derivatives of Glycopeptide Antibiotics
作者:Jan Balzarini、Christophe Pannecouque、Erik De Clercq、Andrey Y. Pavlov、Svetlana S. Printsevskaya、Olga V. Miroshnikova、Marina I. Reznikova、Maria N. Preobrazhenskaya
DOI:10.1021/jm0300882
日期:2003.6.1
natural antibacterial glycopeptideantibiotics such as vancomycin, eremomycin, ristocetin A, teicoplanin A(2)-2, DA-40926, their aglycons, and also the products of their partial degradation with a destroyed or modified peptide core show marked anti-retroviral activity in cell culture. In particular, aglycon antibiotic derivatives containing various substituents of a preferably hydrophobic nature displayed